| CYCC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CYCC shares outstanding history going back to 5/31/2016:
Also see: CYCC Market Cap History CYCC YTD Return |
CYCC Shares Outstanding History — Cyclacel Pharmaceuticals Share Count Over Time
As of 8/11/2025 Cyclacel Pharmaceuticals has 2.24 million CYCC shares outstanding. Investors often track the CYCC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CYCC share count trends over time, with 39 historical shares outstanding datapoints presented, dating back to 5/31/2016.
| CYCC Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CYCC Historical Shares Outstanding: +226.31% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CYCC Stock Price Chart |
| About Bio Green Med Solution Inc |
| Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The epigenetic/anti-mitotic program is evaluating plogosertib, in solid tumors and hematological malignancies. We show 39 historical shares outstanding datapoints in our coverage of CYCC's shares outstanding history. Understanding the changing numbers of CYCC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CYCC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CYCC by allowing them to research CYCC shares outstanding history as well as any other stock in our coverage universe. |
| CYCC Current Stock Quote |
Quotes delayed 20 minutes  Free CYCC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CYCC Share Performance |
| Shares Outstanding Peers |
| Cyclacel Pharmaceuticals (CYCC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CYCN Shares Outstanding History CYH Shares Outstanding History CYPH Shares Outstanding History CYRX Shares Outstanding History CYT Shares Outstanding History CYTH Shares Outstanding History CYTK Shares Outstanding History CYTR Shares Outstanding History CYTX Shares Outstanding History DARE Shares Outstanding History More Healthcare companies » |
CYCC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
